The point is that it is misleading (or at least, premature) to say that myocarditis is more likely with the virus than with the vaccine, given that the context

The point is that it is misleading (or at least, premature) to say that myocarditis is more likely with the virus than with the vaccine, given that the context of this discussion is usually around young men and there is recent data that suggests the opposite for this cohort under Moderna (and perhaps Pfizer). Also, what you say is not the case in every country. Many countries are jabbing young men with Moderna.